Gut microbiota interventions may improve glucose and cardiometabolic markers in type 2 diabetes
Key takeaway:
This systematic review found that microbiota-directed strategies, including probiotics, personalized nutrition, and diet changes, were often linked with better glycemic and cardiometabolic markers, but study methods and results varied across trials.
Study at a glance
What was studied
A systematic review of gut microbiota-directed interventions and metabolic outcomes in adults with type 2 diabetes.
Study type
Systematic Review
duration
Medium-Term (3–12 mo)
Intervention
Probiotics
Outcomes
HbA1c, Insulin resistance, LDL cholesterol
Funding
Non-industry sponsored
Main effects
HbA1c ↓ in several included intervention trials
Insulin resistance ↓ in multiple microbiota-targeted strategies
Cardiometabolic markers (lipids, blood pressure, CRP) often improved
Evidence Summary
| Intervention | Outcome | Measured Change | Study Effect |
|---|---|---|---|
 Probiotics (Supplements) |  HbA1c (Glycemic Control) | Decrease | Mixed |
Probiotics (Supplements) |  Insulin resistance (Metabolic Health) | Decrease | Mixed |
Probiotics (Supplements) | LDL cholesterol (Metabolic Health) | Decrease | Mixed |
Unlock Full Evidence Analysis
Create a free account to access effectiveness ratings, evidence strength and depth scores, consistency analysis, and direct links to all supporting studies.
Evidence Suggest
- Several trials reported better glycemic and insulin sensitivity markers after microbiota-directed interventions.
- Some studies found stronger effects with combined or personalized strategies than with standard comparators.
- Outcome variability across studies limits confidence in a single effect size.
Who this applies to
Adults with type 2 diabetes
Keep in Mind
This is a review-level synthesis, not one primary intervention trial.
Between the Lines
- No pooled meta-analysis due to heterogeneity
- Many included trials were short-term
- Several studies had small sample sizes
- Interventions and measured outcomes varied substantially
Unlock Full Analysis
Create a free account to unlock the bias score, detailed effectiveness analysis, and clinical outcomes for this study.
Journal Reference
Ur Rehman M, Saeed H, Omer O, Tashfeen S. Gut Microbiota-Directed Interventions in Type 2 Diabetes: A Systematic Review of Clinical Outcomes and Complication Risk. Cureus. 2025;17(10):e95045. doi:10.7759/cureus.95045
Sources
Ranked by clinical relevance and evidence quality.
Key References
Most relevant evidence and guidance related to this research.
Diabetes Management in Patients with Obesity-Associated Cancers | American Association of Clinical Endocrinology
Abaloparatide Followed by Alendronate Shows Promising Results for Women With Osteoporosis, T2D | American Association of Clinical Endocrinology
Supporting Evidence
Supporting evidence and related resources.
Connecting the Dots: Diabetes, CKD, and CVD Pathways | American Association of Clinical Endocrinology
Episode 39: AACE 2023 Updated Comprehensive Type 2 Diabetes Management Algorithm | American Association of Clinical Endocrinology
Standards of Care in Diabetes—2025
NIDDK: Diabetes Diet, Eating, and Physical Activity
WHO Fact Sheet: Diabetes
Gut Microbiota Modulation in Type 2 Diabetes and Cardiometabolic Risk: A Systematic Review.
13 total sources in this category
No ads. No tracking.
Focused on evidence, not advertising.
Secure & private
Your data is always protected.
Always up to date
New studies added every day.